======= SRA1 =======
== Gene Information ==
* **Official Symbol**: SRA1
* **Official Name**: steroid receptor RNA activator 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10011|10011]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9HD15|Q9HD15]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SRA1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SRA1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603819|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: Both long non-coding and protein-coding RNAs are transcribed from this gene, and they represent alternatively spliced transcript variants. This gene was initially defined as a non-coding RNA, which is a coactivator for several nuclear receptors (NRs) and is associated with breast cancer. It has now been found that this gene is involved in the regulation of many NR and non-NR activities, including metabolism, adipogenesis and chromatin organization. The long non-coding RNA transcripts interact with a variety of proteins, including the protein encoded by this gene. The encoded protein acts as a transcriptional repressor by binding to the non-coding RNA. [provided by RefSeq, Mar 2012].
* **UniProt Summary**: Functional RNA which acts as a transcriptional coactivator that selectively enhances steroid receptor-mediated transactivation ligand-independently through a mechanism involving the modulating N-terminal domain (AF-1) of steroid receptors. Also mediates transcriptional coactivation of steroid receptors ligand- dependently through the steroid-binding domain (AF-2). Enhances cellular proliferation and differentiation and promotes apoptosis in vivo. May play a role in tumorigenesis. {ECO:0000269|PubMed:10199399, ECO:0000269|PubMed:12943696, ECO:0000269|PubMed:14517287, ECO:0000269|PubMed:15147866, ECO:0000269|PubMed:15351741}.
|SRA1|
|steroid receptor RNA activator RNA binding|
|cellular response to estrogen stimulus|
|negative regulation of myoblast differentiation|
|cell leading edge|
|regulation of myoblast differentiation|
|intercellular bridge|
|nuclear receptor transcription coactivator activity|
|response to estrogen|
|microtubule cytoskeleton|
|ribonucleoprotein complex|
|transcription factor complex|
|transcription coactivator activity|
|cell population proliferation|
|negative regulation of cell differentiation|
|apoptotic process|
|negative regulation of developmental process|
|programmed cell death|
|cell death|
|DNA binding|
|regulation of apoptotic process|
|regulation of programmed cell death|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|regulation of cell death|
|positive regulation of RNA metabolic process|
|regulation of cell differentiation|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp116|AICAR 240μM R03 exp116]]|-2.03|
|[[:results:exp165|RO-3306 3 to 4μM on day4 R04 exp165]]|-1.72|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18592
* **Expression level (log2 read counts)**: 3.24
{{:chemogenomics:nalm6 dist.png?nolink |}}